Jie Li Junrong Yan Ran Cao Guanjun Du Guofang Zhao
10.3389/fonc.2020.575739
Front Oncol
2020 Dec 17;10:575739.
egfr-kdd nivolumab osimertinib lung adenocarcinoma targeted next-generation sequencing
CC BY
https://pubmed.ncbi.nlm.nih.gov/33392076/
Case Reports
PMC7773813
33392076
Lung Adenocarcinoma Harboring EGFR Kinase Domain Duplication ( EGFR-KDD) Confers Sensitivity to Osimertinib and Nivolumab: A Case Report
2020